NCT07127705 Rapid Response of Stem Cells and Immune Cells for Efficacy
| NCT ID | NCT07127705 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Natural Immune Systems Inc |
| Condition | Stem Cell Surveillance |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-05-21 |
| Primary Completion | 2025-08-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2025-05-21 with a primary completion date of 2025-08-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal for this clinical trial is to compare rapid effects of four products on stem cells, immune activation, and mitochondrial function. A double-blind, placebo-controlled, cross-over study design will be used.
Eligibility Criteria
Inclusion Criteria: * Healthy adults; * Age 18 - 75 years (inclusive); * BMI between 18.0 and 34.9 (inclusive); * Veins easy to see in one or both arms (to allow for the multiple blood draws); * Willing to comply with study procedures, including: * Maintaining a consistent diet and lifestyle routine throughout the study, * Consistent habit of bland breakfasts on days of clinic visits, * Abstaining from exercising and nutritional supplements on the morning of a study visit, * Abstaining from use of coffee, tea, and soft drinks for at least one hour prior to a clinic visit; * Abstaining from music, candy, gum, computer/cell phone use (airplane mode is allowed), during clinic visits. Exclusion Criteria: * Previous major gastrointestinal surgery (absorption of test product may be altered) (minor surgery not a problem, including previous removal of appendix and gall bladder); * Taking anti-inflammatory medications on a daily basis; * Currently experiencing intense stressful events/ life changes; * Currently in intensive athletic training (such as marathon runners); * Currently taking antipsychotic medications such as clozapine, Risperdal, Abilify, Zyprexa or Seroquel; * An unusual sleep routine (examples: working graveyard shift, irregular routine with frequent late nights, studying, partying); * Unwilling to maintain a constant intake of supplements over the duration of the study; * Anxiety about having blood drawn; * Pregnant, nursing, or trying to become pregnant; * Known food allergies related to ingredients in active test product or placebo.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07127705 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Stem Cell Surveillance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07127705 currently recruiting?
Yes, NCT07127705 is actively recruiting participants. Contact the research team at Gitte@nislabs.com for enrollment information.
Where is the NCT07127705 trial being conducted?
This trial is being conducted at Klamath Falls, United States.
Who is sponsoring the NCT07127705 clinical trial?
NCT07127705 is sponsored by Natural Immune Systems Inc. The trial plans to enroll 24 participants.